|
1.
|
Chonan K, Kikuya M, Araki T, Fujiwara T,
Suzuki M, Michimata M, Hashimoto J, Ohkubo T, Hozawa A, Yamamoto N,
Miyawaki Y, Matsubara M and Imai Y: Device for the self-measurement
of blood pressure that can monitor blood pressure during sleep.
Blood Press Monit. 6:203–205. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Ogihara T, Kikuchi K, Matsuoka H, et al:
The Japanese Society of Hypertension Guidelines for the Management
of Hypertension (JSH 2009). Hypertens Res. 32:3–107. 2009.
View Article : Google Scholar
|
|
3.
|
Croom KF and Plosker GL: Irbesartan: a
review of its use in hypertension and diabetic nephropathy. Drugs.
68:1543–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Marino MR, Langenbacher K, Ford NF and
Uderman HD: Pharmacokinetics and pharmacodynamics of irbesartan in
healthy subjects. J Clin Pharmacol. 38:246–255. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Cazaubon C, Gougat J, Bousquet F,
Guiraudou P, Gayraud R, Lacour C, Roccon A, Galindo G, Barthelemy
G, Gautret B, Bernhart C, Perreaut P, Breliere J, Fur GL and Nisato
D: Pharmacological characterization of SR 47436, a new nonpeptide
AT1 subtype angiotensin II receptor antagonist. J Pharmacol Exp
Ther. 265:826–834. 1993.PubMed/NCBI
|
|
6.
|
Van den Meiracker AH, Admiraal PJ, Janssen
JA, Kroodsma JM, de Ronde WA, Boomsma F, Sissmann J, Blankestijn
PJ, Mulder PG, Man in’t Veld AJ and Schalekamp MADH: Hemodynamic
and biochemical effects of the AT1 receptor antagonist irbesartan
in hypertension. Hypertension. 25:22–29. 1995.PubMed/NCBI
|
|
7.
|
Matsuo S, Imai E, Horio M, Yasuda Y,
Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A:
Collaborators developing the Japanese equation for estimated GFR.
Revised equations for estimated GFR from serum creatinine in Japan.
Am J Kidney Dis. 53:932–935. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Bobrie G, Chatellier G, Genes N, Clerson
P, Vaur L, Vaisse B, Menard J and Mallion JM: Cardiovascular
prognosis of ‘masked hypertension’ detected by blood pressure
self-measurement in elderly treated hypertensive patients. JAMA.
291:1342–1349. 2004.
|
|
9.
|
Ohkubo T, Kikuya M, Metoki H, Asayama K,
Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H and Imai Y:
Prognosis of ‘masked’ hypertension and ‘white-coat’ hypertension
detected by 24-h ambulatory blood pressure monitoring 10-year
follow-up from the Ohasama study. J Am Coll Cardiol. 46:508–515.
2005.
|
|
10.
|
Harada K, Karube Y, Saruhara H, Takeda K
and Kuwajima I: Workplace hypertension is associated with obesity
and family history of hypertension. Hypertens Res. 29:969–976.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Kario K, James GD, Marion R, Ahmed M and
Pickering TG: The influence of work- and home-related stress on the
levels and diurnal variation of ambulatory blood pressure and
neurohumoral factors in employed women. Hypertens Res. 25:499–506.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Parving HH, Lehnert H, Bröchner-Mortensen
J, Gomis R, Andersen S and Arner P; Irbesartan in Patients with
Type 2 Diabetes and Microalbuminuria Study Group: The effect of
irbesartan on the development of diabetic nephropathy in patients
with type 2 diabetes. N Engl J Med. 345:870–878. 2001. View Article : Google Scholar
|
|
13.
|
Lewis EJ, Hunsicker LG, Clarke WR, Berl T,
Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R and Raz I;
Collaborative Study Group: Renoprotective effect of the
angiotensin-receptor antagonist irbesartan in patients with
nephropathy due to type 2 diabetes. N Engl J Med. 345:851–860.
2001. View Article : Google Scholar
|
|
14.
|
Kario K, Pickering TG, Umeda Y, Hoshide S,
Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE and Shimada
K: Morning surge in blood pressure as a predictor of silent and
clinical cerebrovascular disease in elderly hypertensives: a
prospective study. Circulation. 107:1401–1406. 2003. View Article : Google Scholar
|
|
15.
|
Fabia MJ, Abdilla N, Oltra R, Fernandez C
and Redon J: Antihypertensive activity of angiotensin II AT1
receptor antagonists: a systematic review of studies with 24 h
ambulatory blood pressure monitoring. J Hypertens. 25:1327–1336.
2007. View Article : Google Scholar : PubMed/NCBI
|
